Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Explore scenarios where incorporating mutual funds into an index-based portfolio can improve diversification and adaptability.
24,945 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Jane Street resumes bitcoin activity as probes and lawsuits loom. In the latest window, 25.36 BTC, worth $15.08 milli...
NVIDIA CEO Jensen Huang has framed a $40 trillion TAM for labor automation via robotics, prompting a broader look at ...
Micron looks cheaper than its earnings prospects suggest, but a closer look reveals cyclicality, demand swings, and r...
Oil breaks $100 again as Middle East tensions flare, lifting energy stocks and reshaping risk-on bets for 2026. Inves...
Orion (OESX) 2026 earnings reveal a company navigating growth opportunities and profitability challenges. This deep d...
Three giants of U.S. banking posted strong Q1 results, yet each faces a different market reality. JPMorgan sits near ...
In 2026, a disciplined trio of growth ETFs offers a clear path to long-term wealth through earnings-driven expansion,...
Goldman Sachs expands its US Conviction List with four new names pegged for double-digit upside, signaling a continue...
A hypothetical $10,000 Exxon investment at the outbreak of the Iran conflict has produced a mixed bag of results. Her...
Gold retreats while Bitcoin-focused ETFs keep drawing capital, highlighting a widening split in how investors price i...
As market nerves remain tied to crude prices, the VanEck Energy Income ETF (EINC) continues to offer a solid 3.2%-3.6...